Skip to main content
Back to AI Intelligence Briefing
Clinical AIAugust 17, 2026Source: National Center for Biotechnology Information (NCBI) / PMC

Integrating clinical decision support systems, nursing vigilance, and physician prescribing patterns to reduce preventable adverse drug events: a structured evidence-based narrative review on human-AI interface in medication safety

This narrative review examines how AI‑driven clinical decision support can improve medication safety while highlighting risks like algorithmic bias, technology‑induced errors, and reduced clinician vigilance. The authors argue that combining CDS tools with strong human oversight from nurses and physicians is essential to prevent adverse drug events and protect patient safety.

LOG Standards provides this short context and directs readers to the named publisher for the complete report. The source article remains the authoritative account of the underlying reporting.
Read Full Article

About LOG Standards

LOG Standards provides an independent accreditation signal for AI models used in healthcare, helping hospitals, care networks, and AI companies bring clinical AI readiness and governance into clearer conversations.

Our AI Intelligence Briefing tracks the latest developments in AI safety, AI in medicine, mental health AI, clinical AI governance, and regulatory policy — keeping healthcare stakeholders informed about the rapidly evolving AI landscape.